Patent Trial and Appeal BoardMotion to Amend Study4/30/2016
Motion to Amend StudyThere have been more than 4,850 inter partes review, covered business method review, and post-grantreview petitions filed since the inception of the America Invents Act (“AIA”). As of April 30, 2016, the Board hadinstituted and completed 1539 trials1 (either through post-institution termination due to settlement, request foradverse judgment, dismissal, or in a final written decision). Given the number of pending and completed trials, theBoard undertook a study of motions to amend to determine: (1) the number of motions to amend that have beenfiled in AIA trials, both as a cumulative total and by fiscal year; (2) subsequent developments of each motion toamend; (3) the number of motions to amend requesting to substitute claims that are granted, granted-in-part anddenied-in-part, and denied; and (4) the reasons the Board has provided for denying entry of substitute claims.The AIA provides that a patent owner may file a motion to amend its claims during a trial. A motion toamend may involve a request to cancel patent claims, to substitute claims in the patent, or a combination of thetwo. Requests solely to cancel claims typically are granted without substantive review. Requests that seek tosubstitute claims are generally decided only when the panel of judges determines that the claims as originallyissued are unpatentable, because nearly all such motions are contingent on a decision unfavorable to patentabilityon the original claims. Because not all proceedings include a motion to amend, because some proceedings that1Joined or consolidated trials were counted as a single trial for purposes of the motion to amend statistics, becausethis study focuses on the outcome of a motion filed in one of those trials. The number of completed trialsreferenced in the motion to amend statistics, therefore, differs from the total number of petitions referenced in otherBoard statistics depicting outcomes for all petitions that have reached a final disposition.2
include a motion to amend do not result in a final written decision, because not all motions to amend seek tosubstitute claims, and because the Board does not need to reach the merits of a motion to substitute claims whenthe original claims are deemed patentable, the Board has decided the merits of a motion to amend to substituteclaims in only a fraction (118 trials, or 8%) of the 1539 completed AIA trials.These graphs and table below provide the results of the motion to amend study. Graph I is a pie chart thatshows the cumulative number of motions to amend that have been filed in AIA proceedings, both completed andpending. Patent Owners have filed a motion to amend in 192 of the 1539 completed trials (12%), and in 34 of the743 pending trials (5%).Graph II, a pie chart that depicts the subsequent developments of the motions to amend, focuses on theoutcomes of the 192 completed trials in which Patent Owners filed a motion to amend. The panel of judgesdecided a motion to amend requesting to substitute claims in 118 of the 192 completed trials (61%2). In 74 of the192 completed trials (39%3), the motion to amend either: (a) requested solely to cancel claims (17, or 9%), (b) wasrendered moot because the panel of judges found the original claims patentable (16, or 8%), or (c) was not decidedbecause the case terminated prior to a final written decision (41, or 21%).2The label for Graph II indicates 62% rather than 61%. This is because the software program that was used togenerate these graphs apportions rounding errors among each slice of the pie to ensure the percentage labels add upto 100%. Accordingly, a number may be rounded up or down when it typically would not. Here, 0.61458 wasdouble rounded in the pie chart to 62% to ensure the slices add up to 100%.3See n. 2.3
Graph III is a pie chart that depicts the outcomes of the 118 motions to amend requesting to substitute claimsthat were decided, i.e., the number of motions to amend requesting to substitute claims that were granted, grantedin-part and denied-in-part, or denied. A panel of judges granted or granted-in-part and denied-in-part a motion toamend in 6 of the 118 trials (5%) and denied a motion to amend in 112 of the 118 trials (95%).The table to the left of Graph III focuses on the reasons provided in the final written decisions for denyingentry of substitute claims in the 116 trials in which the motion to amend was denied or denied-in-part. The table isdivided into two sections: (1) reasons based in whole or in part on 35 U.S.C., and (2) reasons based solely onprocedure. The final written decision set forth at least one statutory reason for denying or denying-in-part a motionto amend in 94 of the 116 trials (81%), and based a denial solely on procedural reasons in 22 of the 116 trials(19%). For purposes of the study, a denial based on a patent owner’s failure to show that the substitute claims arepatentable over the “prior art in general” was classified as a procedural reason. Of the 116 trials in which themotion to amend was denied or denied-in-part, only 1 trial had a motion to amend denied based solely on a patentowner’s failure to show patentability over the prior art in general.4As set forth above, the motion to amend study also determined the number of motions to amend filed in eachfiscal year. The bar chart corresponding to the data shows the total number of motions to amend filed in a givenfiscal year. The data for fiscal year 2016 is from October 1, 2015 through April 30, 2016.4See Idle Free Systems, Inc. v. Bergstrom, Inc., Case IPR2012-00027, slip op. 26–38 (PTAB January 7, 2014)(Paper 66).4
How Many Motions to Amend Are Filed?Completed Trials w/oMTACompleted Trials withMTAPending Trials withMTAPending Trials w/oMTASubsequent Developments of the Motions toAmend134759%168%I.2282 Trials1928%34, 2%70931%Moot b/c ClaimsPatentable4121%179%II.192 Trialswith MTA11862%MTA Withdrawn orCase Settled, Req. Adv.J, or DismissedMTA Solely to CancelClaimsMTA Substitute ClaimsDecided[to next slide]Data current as of: 4/30/20165
Reasons Provided for Denying Entry of Substitute Claims*Reason Given # of CasesPctReasons Based in Whole or Part on 35 U.S.C.:101Non-Statutory Subject Matter76%112(a)Written Description98%112(b)Definiteness11%102/103 Anticipated/Obvious Over Art of Record4135%316(d)(3)Claims Enlarge Scope of Patent65%316(d)(1)(B)Unreasonable # Substitute Claims33%Multiple Statutory Reasons Given**2723%Reasons Based Solely on Procedure:Cases Where Only Procedural Reasons Given2219%Totals:116100%* 116 MTAs requesting entry of substitute claims have been deniedin whole or in part.** Of the "Multiple Statutory Reasons Given" trials,24 of the 27 trials included "Anticipated/Obvious" as a reason.Data current as of: 4/30/2016How Many Motions to Amend SubstitutingClaims Are Granted?III.118MTAs WithSubstituteClaims Decided2, 2%Granted4, 3%Granted in PartDenied11295%6
How Many Motions to Amend Were Filed in Each Fiscal Year?1009080MTAs Filed in FY70605040302010020132014Trial PendingTrial Complete499220152016925501Data for FY2016 are from October 1, 2015–April 30, 2016.7
Apr 30, 2016 · These graphs and table below provide the results of the motion to amend study. Graph I is a pie chart that shows the cumulative number of motions to amend that have been filed in AIA proceedings, both completed and pending. Patent Owners have filed a motion to amend in 192 of the 1539 completed trials (12%), and in 34 of the 743 pending trials .
Australian Patent No. 692929 Australian Patent No. 708311 Australian Patent No. 709987 Australian Patent No. 710420 Australian Patent No. 711699 Australian Patent No. 712238 Australian Patent No. 728154 Australian Patent No. 731197 PATENTED NO. EP0752134 PATENTED NO.
Trial Statistics IPR, PGR, CBM Patent Trial and Appeal Board January 2020. 3 Petitions by Trial Type (All Time: Sept. 16, 2012 to Jan. 31, 2020) Trial types include Inter Partes Review (IPR), Post Grant Review (PGR), and Covered Business Method (CBM). 4 Petitions Filed by Technology in FY20
Trial Statistics IPR, PGR, CBM Patent Trial and Appeal Board September 2020. IPR 11,299 93%. CBM 602 5%. PGR 246 2%. 12,147 Total. 3. Petitions by Trial Type (All Time: Sept. 16, 2012 to Sept. 30, 2020) Trial types include Inter Partes Review (IPR ), Post Grant Review (PGR ), and Covered
a) against refusal of a patent application, b) to correct the description, claims, and/or drawings after the grant of a patent, c) against a decision to grant a patent. An appeal shall be filed in writing to the Patent Appeal Commission, with a copy to the Patent Office, and is subject to the payment of a fee (see Annex ID.I).
A careful reading of the appellant's grounds of Appeal reveals that they all seek to attack the trial court and Court of Appeal's reliance on Exhibit 6 to resolve the trial and appeal in favour of the respondent. Thus, all the grounds of appeal fall substantially under Ground A, i.e., the judgment is against the weight of evidence.
Patent-Mapper, which maps the location of patents within the U.S., given a selected patent application year, patent state, and patent class. . Along with the patent, the Longitude and the Latitude will also be provided for geolocation purposes. Other information such as invent
Book indicating when the patent was listed PTAB manually identified biologic patents as any patent potentially covering a Purple Book-listed product and any non-Orange Book-listed patent directed to treating a disease or condition The litigation referenced in this study is limited to litigation that the parties to a
TECHNICAL INFORMATION PLEXIGLAS Solid sheet, block, multi-skin sheet, corrugated sheet, tube and rod . Patent EP 530 617 3 Europ. Patent EP 548 822 4 Europ. Patent EP 149 182 5 Europ. Patent EP 733 754 6 Europ. Patent EP 776 931 7 Europ. Patent EP 600 332. PLEXIGLAS Ref. No. 211-1 02/2 Page 4/7